EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Establishment and characterization of a novel cancer stem‐like cell of cholangiocarcinoma

Orasa Panawan, Atit Silsirivanit iD, Chih-Hsiang Chang, Siyaporn Putthisen, Piyanard Boonnate, Taro Yokota, Yuki Nishisyama-Ikeda, Marutpong Detarya, Kanlayanee Sawanyawisuth, Worasak Kaewkong, Kanha Muisuk, Sukanya Luang und 8 weitere

Cancer Science · 2023

DOI: 10.1111/cas.15812 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Science, 2023. Verfasst von Orasa Panawan und 19 weiteren Autor:innen. Beteiligte Einrichtung: Department of Tumor Genetics and Biology, Graduate School of Medical Sciences, Faculty of Life Sciences, Kumamoto University, Kumamoto, Japan. Hauptthemen laut MEDLINE: Cholangiocarcinoma, Bile Duct Neoplasms. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Japan Society for the Promotion of Science, Khon Kaen University, National Research Council of Thailand.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cholangiocarcinoma (CCA) is an aggressive malignant tumor of bile duct epithelia. Recent evidence suggests the impact of cancer stem cells (CSC) on the therapeutic resistance of CCA; however, the knowledge of CSC in CCA is limited due to the lack of a CSC model. In this study, we successfully established a stable sphere‐forming CCA stem‐like cell, KKU‐055‐CSC, from the original CCA cell line, KKU‐055. The KKU‐055‐CSC exhibits CSC characteristics, including: (1) the ability to grow stably and withstand continuous passage for a long period of culture in the stem cell medium, (2) high expression of stem cell markers, (3) low responsiveness to standard chemotherapy drugs, (4) multilineage differentiation, and (5) faster and constant expansive tumor formation in xenograft mouse models. To identify the CCA‐CSC‐associated pathway, we have undertaken a global proteomics and functional cluster/network analysis. Proteomics identified the 5925 proteins in total, and the significantly upregulated proteins in CSC compared with FCS‐induced differentiated CSC and its parental cells were extracted. Network analysis revealed that high mobility group A1 (HMGA1) and Aurora A signaling through the signal transducer and activator of transcription 3 pathways were enriched in KKU‐055‐CSC. Knockdown of HMGA1 in KKU‐055‐CSC suppressed the expression of stem cell markers, induced the differentiation followed by cell proliferation, and enhanced sensitivity to chemotherapy drugs including Aurora A inhibitors. In silico analysis indicated that the expression of HMGA1 was correlated with Aurora A expressions and poor survival of CCA patients. In conclusion, we have established a unique CCA stem‐like cell model and identified the HMGA1‐Aurora A signaling as an important pathway for CSC‐CCA.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CholangiocarcinomaBile Duct NeoplasmsHumansMiceAnimalsHMGA1a ProteinNeoplastic Stem CellsBile Ducts, IntrahepaticCell Line, TumorCell Proliferation

Stichwörter der Autor:innen

HMGA1bile ductcancer stem cellcholangiocarcinomaliver

Substanzen

HMGA1a Protein

Autor:innen und Institutionen

  • Department of Tumor Genetics and Biology, Graduate School of Medical Sciences, Faculty of Life Sciences, Kumamoto University, Kumamoto, Japan.
  • Department of Biochemistry, Faculty of Medicine, Khon Kaen University, Khon Kaen, Thailand.
  • Cholangiocarcinoma Research Institute, Khon Kaen University, Khon Kaen, Thailand.
  • Division of Hematopoiesis, Joint Research Center for Human Retrovirus Infection, Kumamoto University, Kumamoto, Japan.
  • Department of Biochemistry, Faculty of Medical Sciences, Naresuan University, Phitsanulok, Thailand.
  • Department of Forensic Medicine, Faculty of Medicine, Khon Kaen University, Khon Kaen, Thailand.

ORCID-Profile: Atit Silsirivanit, Yoshihiro Komohara, Norie Araki

Förderung

  • Japan Society for the Promotion of Science
  • Khon Kaen University
  • National Research Council of Thailand

Zitieren

APA

Panawan, O., Silsirivanit, A., Chang, C. H., Putthisen, S., Boonnate, P., Yokota, T., Nishisyama-Ikeda, Y., Detarya, M., Sawanyawisuth, K., Kaewkong, W., Muisuk, K., Luang, S., Vaeteewoottacharn, K., Kariya, R., Yano, H., Komohara, Y., Ohta, K., Okada, S., Wongkham, S., & Araki, N. (2023). Establishment and characterization of a novel cancer stem‐like cell of cholangiocarcinoma. Cancer Science. https://doi.org/10.1111/cas.15812

Vancouver

Panawan O, Silsirivanit A, Chang CH, Putthisen S, Boonnate P, Yokota T, et al. Establishment and characterization of a novel cancer stem‐like cell of cholangiocarcinoma. Cancer Science. 2023. doi:10.1111/cas.15812

BibTeX
@article{Panawan2023,
  author = {Panawan, Orasa and Silsirivanit, Atit and Chang, Chih-Hsiang and Putthisen, Siyaporn and Boonnate, Piyanard and Yokota, Taro and Nishisyama-Ikeda, Yuki and Detarya, Marutpong and Sawanyawisuth, Kanlayanee and Kaewkong, Worasak and Muisuk, Kanha and Luang, Sukanya and Vaeteewoottacharn, Kulthida and Kariya, Ryusho and Yano, Hiromu and Komohara, Yoshihiro and Ohta, Kunimasa and Okada, Seiji and Wongkham, Sopit and Araki, Norie},
  title = {Establishment and characterization of a novel cancer stem‐like cell of cholangiocarcinoma},
  journal = {Cancer Science},
  year = {2023},
  doi = {10.1111/cas.15812}
}
Kostenlos starten →